Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: The PLATINO study

dc.contributor.authorVarela, Maria Victorina Lopez
dc.contributor.authorMuino, Adriana
dc.contributor.authorPadille, Rogelio Perez
dc.contributor.authorJardim, Jose Roberto
dc.contributor.authorTalamo, Carlos
dc.contributor.authorde Oca, Maria Montes
dc.contributor.authorValdivia, Gonzalo
dc.contributor.authorPertuze, Julio
dc.contributor.authorHalbert, Ron
dc.contributor.authorMenezes, Ana Maria
dc.contributor.authorMarquez, Maria
dc.contributor.authorHallal, Pedro
dc.contributor.authorMoreno, Dolores
dc.contributor.authorRosa, Fernanda
dc.contributor.authorCarnelier, Aquiles
dc.date.accessioned2024-01-10T14:22:17Z
dc.date.available2024-01-10T14:22:17Z
dc.date.issued2008
dc.description.abstractOBJECTIVE: PLATINO project is a population-based study designed to determine the prevalence of chronic obstructive pulmonary disease (COPD) in S (a) over tildeo Paulo, Brazil; Mexico City, Mexico; Montevideo, Uruguay; Santiago de Chile, Chile; and Caracas, Venezuela. The objective of this portion of PLATINO was to describe preventive and pharmacological treatment of COPD patients and factors associated with such treatment.
dc.description.abstractPATIENTS AND METHODS: Eligible subjects completed a questionnaire and underwent postbronchodilator spirometry.
dc.description.abstractRESULTS: Of the total of 5529 individuals who answered items referring to treatment, 758 had COPD (ratio of postbronchodilator forced expiratory volume in 1 second to forced vital capacity of <0.7), and 86 of them had been previously diagnosed by a physician. Among all COPD patients, only half of smokers or former smokers had been advised to quit and 24.7% had received some type of respiratory medication. Only 13.5% had used inhaled corticosteroids, and those were the patients with the most severe disease. In the group of patients who had a previous medical diagnosis of COPD, 69% of the smokers or former smokers had been advised to quit by a physician and 75.6% had received respiratory medication in the preceding year: 43% reported having used inhaled medication and 36% had used bronchodilators. Rates of vaccination against influenza and the use of mucolytic drugs and inhalers varied from one health care facility to another. All drug prescriptions were based on previous spirometry.
dc.description.abstractCONCLUSIONS: Spirometry emerged not only as a diagnostic tool, but also as a factor associated with treatment, against a background of uneven use of available health care resources in these 5 Latin American cities.
dc.format.extent7 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/S1579-2129(08)60016-6
dc.identifier.eissn1579-2129
dc.identifier.issn0300-2896
dc.identifier.pubmedidMEDLINE:18361870
dc.identifier.uri10.1016/S1579-2129(08)60016-6
dc.identifier.wosidWOS:000253402700002
dc.information.autorucMedicina;Pertuze J;S/I;99166
dc.information.autorucMedicina;Valdivia G;S/I;57007
dc.issue.numero2
dc.language.isoes
dc.nota.accesocontenido parcial
dc.pagina.final64
dc.pagina.inicio58
dc.publisherELSEVIER ESPANA SLU
dc.revistaARCHIVOS DE BRONCONEUMOLOGIA
dc.rightsacceso restringido
dc.subjectchronic obstructive pulmonary disease (COPD)
dc.subjectpopulation-based study
dc.subjectpreventive treatment
dc.subjectrespiratory medication
dc.subjectCLINICAL-PRACTICE
dc.subjectCOPD
dc.subjectGUIDELINES
dc.subjectPREVALENCE
dc.subjectMORTALITY
dc.subjectSMOKING
dc.subjectCOSTS
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleTreatment of chronic obstructive pulmonary disease in 5 Latin American cities: The PLATINO study
dc.typeartículo
dc.volumen44
sipa.codpersvinculados99166
sipa.codpersvinculados57007
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Treatment of chronic obstructive pulmonary disease in 5 Latin American cities - The PLATINO study.pdf
Size:
2.65 KB
Format:
Adobe Portable Document Format
Description: